4
Changes in Ownership
Ultragenyx Pharmaceutical Inc. Filed Acc 0001209191-20-049130
President & CEO sold 30,000 shares at $82.63 ($2,478,900)
From the SEC's structured data for this filing
Trades in this filing
KAKKIS EMIL D · President & CEO
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2020-09-01 | Sale : show line 1 in the form | −30,000 | $82.63 | $2,478,900 | 2,389,741 | I |
| Open-market sales · 30,000 sh · avg $82.63 · $2,478,900 | ||||||
Loading xslF345X03/doc4.xml…